|
regulation of deadenylation-dependent decapping of nuclear-transcribed mRNA
|
GO_0106288 |
[Any process that modulates the frequency, rate or extent of deadenylation-dependent decapping of nuclear-transcribed mRNA.] |
|
GO_0106287
|
GO_0106287 |
|
|
(E)-caffeate-CoA ligase activity
|
GO_0106286 |
[Catalysis of the reaction: (E)-caffeate + ATP + CoA = (E)-caffeoyl-CoA + AMP + diphosphate.] |
|
positive regulation of mitotic cytokinesis
|
GO_1903490 |
[Any process that activates or increases the frequency, rate or extent of mitotic cytokinesis.] |
|
regulation of mitotic cytokinesis
|
GO_1902412 |
[Any process that modulates the frequency, rate or extent of mitotic cytokinesis.] |
|
response to acetylsalicylate
|
GO_1903492 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of an aspirin (acetylsalicylate) stimulus. Aspirin is a non-steroidal anti-inflammatory drug with moA cyclooxygenase inhibitor activity.] |
|
response to simvastatin
|
GO_1903491 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a simvastatin stimulus. Simvastatin is a statin used as a cholesterol-lowering and anti-cardiovascular disease drug.] |
|
response to dehydroepiandrosterone
|
GO_1903494 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dehydroepiandrosterone stimulus.] |
|
response to clopidogrel
|
GO_1903493 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a clopidogrel stimulus. Clopidogrel is a is an oral, thienopyridine-class antiplatelet agent used to inhibit blood clots in coronary artery disease, peripheral vascular disease, and cerebrovascular disease.] |
|
response to 11-deoxycorticosterone
|
GO_1903496 |
[Any process that results in a change in state or activity of a cell or an organism (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 11-deoxycorticosterone stimulus.] |
|
cellular response to dehydroepiandrosterone
|
GO_1903495 |
[Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a dehydroepiandrosterone stimulus.] |
|
bundle sheath cell differentiation
|
GO_1903498 |
[The process in which a relatively unspecialized cell acquires the specialized features of a bundle sheath cell.] |
|
cellular response to 11-deoxycorticosterone
|
GO_1903497 |
[Any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a 11-deoxycorticosterone stimulus.] |
|
regulation of mitotic actomyosin contractile ring assembly
|
GO_1903499 |
[Any process that modulates the frequency, rate or extent of mitotic actomyosin contractile ring assembly.] |
|
chenodeoxycholate 7-alpha-dehydrogenase (NAD+) activity
|
GO_0106281 |
[Catalysis of the reaction: chenodeoxycholate + NAD+ = 7-oxolithocholate + H+ + NADH.] |
|
positive regulation of UDP-N-acetylglucosamine biosynthetic process
|
GO_0106280 |
[Any process that activates or increases the frequency, rate or extent of the UDP-N-acetylglucosamine biosynthetic process.] |
|
regulation of UDP-N-acetylglucosamine biosynthetic process
|
GO_0106278 |
[Any process that modulates the frequency, rate or extent of the UDP-N_acetylglucosamine biosynthetic process.] |
|
ursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
|
GO_0106283 |
[Catalysis of the reaction: NAD+ + ursodeoxycholate = 7-oxolithocholate + H+ + NADH.] |
|
isoursodeoxycholate 7-beta-dehydrogenase (NAD+) activity
|
GO_0106282 |
[Catalysis of the reaction: 3beta,7beta-dihydroxy-5beta-cholan-24-oate + NAD+ = 3beta-hydroxy-7-oxo-5beta-cholan-24-oate + H+ + NADH.] |
|
biliverdin reductase (NADP+) activity
|
GO_0106277 |
[Catalysis of the reaction: bilirubin IXalpha + NADP+ = biliverdin IXalpha + NADPH + H+.] |